AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CBD spray tested to calm anxiety in Alzheimer's patients
Symptom relief OngoingThis early-stage study tested a high-CBD, low-THC liquid spray for 8 weeks in 12 older adults with mild cognitive impairment or mild-to-moderate Alzheimer's who had significant anxiety or agitation. The goal was to see if it could reduce these behavioral symptoms safely. The stud…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: EARLY_PHASE1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
Thousands to be monitored for safety of agitation inhaler
Knowledge-focused TerminatedThis study tracks the safety of ADASUVE, an inhaled medication for calming agitation in people with schizophrenia or bipolar I disorder. Researchers will monitor up to 10,000 patients in real-world emergency or hospital settings to record any side effects. The goal is to better u…
Matched conditions: AGITATION,PSYCHOMOTOR
Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC